FOLLOW-UP OF PATIENTS WITH COVID-19.

University Hospital, Strasbourg, France

Overview

Some patients admitted to intensive care for a severe form of COVID-19 could have respiratory, cardiac, renal and neurological sequelae in the medium or long term. The results of this research will allow an improvement in the understanding and management of patients in the medium and long term.

Study Type

OBSERVATIONAL

Conditions

Patient Admitted to Intensive Care Unit for COVID-19

Interventions

Follow-up of patients with COVID-19OTHER

The presence of sequelae, number of re-hospitalizations, date of death and cost of health expenditure will be collected. The Quality of life score (SF-36 questionnaire) and the Pittsburgh sleep quality index (PSQI questionnaire) will be completed by patients.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient admitted to intensive care unit for COVID-19 * Adult patient ≥ 18 years old * Subject having expressed his non-opposition to the research * Subject affiliated to a social health insurance protection scheme or beneficiary of such a scheme Exclusion Criteria: * Subject under safeguard of justice * Patient under guardianship or curatorship

Locations (1)

Hopitaux Universitaires de Strasbourg

Strasbourg, France

Outcomes

Primary Outcomes

The presence of respiratory, renal, cardiac, motor, neurological, and psychological sequelae will be assessed by specialist doctors during the 12 months following the patient's discharge from intensive care.

Time frame: The primary endpoint will be measured during 12 months following the patient's discharge from intensive care.

Secondary Outcomes

1) The sequelae by type of impairment will be assessed by specialist doctors at 3, 6 and 12 months

Time frame: At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion

2) Number of re-hospitalizations at 3, 6 and 12 months

Time frame: At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion

3) Date of death

Time frame: Date of death will be collected from inclusion to M12 (12 months after patient inclusion)

4.1) Quality of life score (SF-36 questionnaire) at 3, 6 and 12 months

Time frame: At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion

4.2) The Pittsburgh sleep quality index (PSQI questionnaire) at 3, 6 and 12 months

Time frame: At M3 (+/-15 days) : 3 months after patient inclusion-At M6 (+/-15 days) : 6 months after patient inclusion-At M12 (+/-15 days) : 12 months after patient inclusion

5) Cost of health expenditure

Time frame: The cost of health expenditure will be collected from inclusion to M12 (12 months after patient inclusion)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.